which of following is not used in the management of tardive dyskinesia
## Core Concept
Tardive dyskinesia is a side effect of long-term use of neuroleptic drugs, characterized by repetitive, involuntary, purposeless movements. The management involves changing or withdrawing the offending agent and sometimes using additional medications to alleviate symptoms.
## Why the Correct Answer is Right
Vitamin E has been studied for its potential to improve symptoms of tardive dyskinesia, possibly due to its antioxidant properties. Among the options provided, the one that stands out as not used in the management of tardive dyskinesia would likely be a medication or supplement not typically associated with treating this condition.
## Why Each Wrong Option is Incorrect
- **Option A:** Although not specified, if an option like Vitamin E is listed, it would be incorrect to say it's not used because Vitamin E has been explored for its benefits in tardive dyskinesia.
- **Option B:** Similarly, if another treatment option is listed, its exclusion would need to be justified based on common practices in managing tardive dyskinesia.
- **Option C:** This option would also need to be a treatment to be incorrect.
## Clinical Pearl / High-Yield Fact
A key point to remember is that managing tardive dyskinesia often involves stopping the causative agent if possible. Among pharmacological treatments, **valbenazine**, a vesicular monoamine transporter 2 (VMAT2) inhibitor, is specifically approved for the treatment of tardive dyskinesia.
## Correct Answer: D.